Past Podcast Episodes

Mask mandates have mostly ended, and bars, restaurants, public buildings, and other businesses no longer require proof of vaccination. It looks like the COVID-19 pandemic is over. Except for the fact that we're seeing cases of the latest COVID subvariant continue to rise in cities across the country and around the world. So, how do we navigate this post-pandemic world? And if you happen to be immunocompromised, how do you stay safe?

Dr. Nancy Sicotte

Joining me as she has throughout the pandemic, with an update including the steps you can take to stay safe as the world re-opens is Dr. Nancy Sicotte. Dr. Sicotte is a professor and Chair of the Department of Neurology at Cedars-Sinai Medical Center in Los Angeles. Dr. Sicotte also Chairs the National MS Society's National Medical Advisory Committee and she leads the MS Society's COVID-19 Advisory Group.

We're also talking about a workshop that brought together a group of global experts to weigh in on autologous hematopoietic stem cell transplantation (aHSCT) as a viable treatment for MS.

We're sharing the details about an upcoming clinical trial that will test a myelin-restoring treatment for people with relapsing-remitting MS.

Evidence from multiple studies shows that members of the Black and Hispanic communities who live with MS can experience a more severe disease course and a higher disability burden. We'll share the details of a presentation from the Academy of American Neurology annual meeting that sheds new light on what may be driving these disparities.

And we'll tell you how you can register to participate in the National African-Americans with MS Registry.

We have a lot to talk about! Are you ready for RealTalk MS??!

Welcome to the Next Normal! :22

ECTRIMS hosts an Autologous Hematopoietic Stem Cell Transplantation (aHSCT) workshop 1:45

FDA Approves clinical trial for a myelin-restoring treatment 6:04

New data may explain racial and ethnic disparities in MS disease severity and treatment 7:45

The National African Americans with MS Registry 10:13

Dr. Nancy Sicotte explains what people with MS need to know to stay safe as they re-enter a post-pandemic world 11:52

Share this episode 32:31

Download the RealTalk MS app for your iOS or Android device 32:51

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/242

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society COVID-19 Vaccine Guidance for People Living with MS
https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance

ECTRIMS Focused Workshop: Autologous Hematopoietic Stem Cell Transplantation For Treatment of MS and Related Diseases
https://ectrims.eu/ongoing-educational-programmes/focused-workshops

National MS Society Recommendations for aHSCT-Bone Marrow Transplant for MS
https://nationalmssociety.org/About-the-Society/News/National-MS-Society-Releases-Recommendations-for-a

National African Americans with MS Registry
https://www.naamsr.org

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 242
Guests: Dr. Nancy Sicotte

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

I spent last week attending the American Academy of Neurology (AAN) Annual Meeting and in this week's episode of RealTalk MS, I'm sharing an overview of what I saw and what I heard.

Each year at the AAN meeting, the American Academy of Neurology and the National MS Society award the John Dystel Prize for MS Research. Joining me on today's podcast is this year's recipient of the Dystel Prize, Professor Xavier Montalban.

We're also talking about how the COVID-19 pandemic has affected MS research and clinical care.

We're sharing encouraging news about two potential disease-modifying therapies.

And we'll share some of the over-arching themes that kept popping up in a number of different meetings, presentations, and conversations during the AAN annual meeting.

We have a lot to talk about! Are you ready for RealTalk MS??!

The impact of the pandemic on MS research and clinical care :53

Results of Phase 2 extension study show Evobrutinib effective in reducing relapse rates in relapsing forms of MS 4:53

Results of Ublituximab Phase 3 post-hoc analyses announced 7:16

Dr. Stephen Hauser receives the Scientific Breakthrough Award 9:25

The importance of making complex science easy to understand for people affected by MS 10:29

The importance of increasing clinical trial participation among members of minority communities 12:48

The importance of caring for the caregiver 14:04

John Dystel Prize for MS Research awarded to Prof. Xavier Montalban 15:40

My conversation with John Dystel Prize recipient Professor Xavier Montalban 16:25

Share this episode 24:51

Have you downloaded the RealTalk MS app? 25:12